Richard Pazdur Eyed for FDA Chief
Update: 2025-11-11
Description
On November eleventh, a significant development in pharmaceutical regulation emerged: the U.S. Food and Drug Administration is poised to appoint oncology expert Richard Pazdur as the nations top drug regulator. This potential appointment, reported by The Washington Post, could signal a renewed focus on cancer-related drug development and approval processes. However, the FDA has not yet made an official announcement, and the formal announcement is eagerly awaited by many in the medical and pharmaceutical communities. This potential leadership change could shape the future of drug regulation in the United States for years to come.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel




